281 related articles for article (PubMed ID: 27721610)
1. Caspase-3 expression in normal oral epithelium, oral submucous fibrosis and oral squamous cell carcinoma.
Veeravarmal V; Austin RD; Siddavaram N; Thiruneelakandan S; Nassar MH
J Oral Maxillofac Pathol; 2016; 20(3):445-452. PubMed ID: 27721610
[TBL] [Abstract][Full Text] [Related]
2. Expression of β1integrin in normal epithelium, oral submucous fibrosis and oral squamous cell carcinoma.
Veeravarmal V; Austin RD; Nagini S; Nassar MHM
Pathol Res Pract; 2018 Feb; 214(2):273-280. PubMed ID: 29113685
[TBL] [Abstract][Full Text] [Related]
3. Dysplastic features relevant to malignant transformation in atrophic epithelium of oral submucous fibrosis: A preliminary study.
Sarode SC; Chaudhary M; Gadbail A; Tekade S; Patil S; Sarode GS
J Oral Pathol Med; 2018 Apr; 47(4):410-416. PubMed ID: 29478271
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
Choudhari S; Masne S; Bhandare P; Dhumal S
J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
[TBL] [Abstract][Full Text] [Related]
5. CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma.
Silva LC; Fonseca FP; Almeida OP; Mariz BA; Lopes MA; Radhakrishnan R; Sharma M; Kowalski LP; Vargas PA
Med Oral Patol Oral Cir Bucal; 2020 Jan; 25(1):e49-e55. PubMed ID: 31880289
[TBL] [Abstract][Full Text] [Related]
6. The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis.
Chaudhary M; Bajaj S; Bohra S; Swastika N; Hande A
J Oral Maxillofac Pathol; 2015; 19(2):122-7. PubMed ID: 26604484
[TBL] [Abstract][Full Text] [Related]
7. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin Expression in Premalignant Lesions, Premalignant Conditions, Oral Squamous Cell Carcinoma, and Normal Mucosa: An Immunohistochemical Study.
Kalaimani G; Rao UDK; Joshua E; Ranganathan K
Cureus; 2023 Aug; 15(8):e44266. PubMed ID: 37772225
[TBL] [Abstract][Full Text] [Related]
9. Expression of Proliferating Cell Nuclear Antigen (PCNA) in Oral Submucous Fibrosis: An Immunohistochemical Study.
Keshav R; Narayanappa U
J Clin Diagn Res; 2015 May; 9(5):ZC20-3. PubMed ID: 26155556
[TBL] [Abstract][Full Text] [Related]
10. Significance of HIF-1α and CD105 in establishing oral squamous cell carcinoma associated with oral submucous fibrosis a distinct clinicopathological entity.
Hande AH; Chaudhary MS; Gadbail AR; Gawande MN; Patil SK; Zade PR; Sharma PN; Jaiswal SG; Sonone AM
J Cancer Res Ther; 2022; 18(1):33-41. PubMed ID: 35381759
[TBL] [Abstract][Full Text] [Related]
11. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
Raju K L; Haragannavar VC; Patil S; Rao RS; Nagaraj T; Augustine D; Venkatesiah SS; Nambiar S
Pathol Oncol Res; 2020 Jul; 26(3):1573-1582. PubMed ID: 31489575
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of myofibroblasts in oral submucous fibrosis and oral squamous cell carcinoma: The pathogenesis and correlation.
Gandhi P; Prasad UC
Dent Res J (Isfahan); 2017; 14(5):314-320. PubMed ID: 29109745
[TBL] [Abstract][Full Text] [Related]
13. Better grade of tumor differentiation of oral squamous cell carcinoma arising in background of oral submucous fibrosis.
Sarode SC; Sarode GS
Med Hypotheses; 2013 Oct; 81(4):540-3. PubMed ID: 23891040
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of extracellular matrix changes among oral submucous fibrosis and oral squamous cell carcinoma patients of Malwa region of Punjab using special histochemical stains: An insight into cancerous transformation.
Gandhi P; Singh HP; Thippeswamy HS; Sodhi SPS; Kaur M; Laskar N
J Oral Maxillofac Pathol; 2023; 27(3):600. PubMed ID: 38033958
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.
Angadi PV; Krishnapillai R
Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review.
Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K
J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571
[TBL] [Abstract][Full Text] [Related]
18. Expression of p63 and Proliferating Cell Nuclear Antigen in Oral Submucous Fibrosis.
Suwasini S; Shrikaar M; Kumari N; Singh A; Kumari K; Kumar M
J Int Soc Prev Community Dent; 2021; 11(4):448-456. PubMed ID: 34430507
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 (COX-2) Expression in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Aparnadevi P; Nirmal RM; Veeravarmal V; Nandini DB; Kalyani C; Singh DN; Yoithapprabhunath TR
J Pharm Bioallied Sci; 2022 Jul; 14(Suppl 1):S769-S773. PubMed ID: 36110596
[TBL] [Abstract][Full Text] [Related]
20. Redefining epithelial characterization in oral submucous fibrosis using morphometric analysis.
Rathore AS; Gupta A; Shetty DC; Kumar K; Dhanapal R
J Oral Maxillofac Pathol; 2017; 21(1):36-40. PubMed ID: 28479684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
